Does MDR-1 G2677T/A polymorphism really associate with ovarian cancer response to paclitaxel chemotherapy?

Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6204. doi: 10.1158/1078-0432.CCR-06-1374.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Female
  • Genetic Variation
  • Humans
  • Neoplasm Staging
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / pathology
  • Paclitaxel / therapeutic use*
  • Poland
  • Polymorphism, Single Nucleotide*

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Paclitaxel